Opko Health (OPK) Shares Outstanding (Weighted Average) (2010 - 2026)

Opko Health has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $758.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 13.0% year-over-year to $758.9 million; the trailing twelve-month figure through Mar 2026 stood at $758.9 million (up 13.0% YoY), and the FY2025 full-year result was $751.1 million, up 8.23% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $758.9 million, up from $751.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $788.0 million in Q2 2025, with the low at $660.3 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $728.7 million across 5 years, with a median of $750.4 million in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) increased 16.03% — and 2024, when it slipped 7.68%.
• Opko Health's Shares Outstanding (Weighted Average) stood at $719.1 million in 2022, then climbed by 4.55% to $751.8 million in 2023, then fell by 7.68% to $694.0 million in 2024, then increased by 8.23% to $751.1 million in 2025, then rose by 1.03% to $758.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $758.9 million (Q1 2026), $751.1 million (Q4 2025), and $777.2 million (Q3 2025), per Business Quant data.